Reduced Plasma Levels of Very-Long-Chain Dicarboxylic Acid 28:4 in Italian and Brazilian Colorectal Cancer Patient Cohorts

Reduced Plasma Levels of Very-Long-Chain Dicarboxylic Acid 28:4 in Italian and Brazilian Colorectal Cancer Patient Cohorts

Background: There are currently no blood-based biomarkers for early diagnosis of colorectal cancer. Previous research has suggested that very-long-chain dicarboxylic acid (VLCDCA) 28:4 might be such a biomarker. Methods: Using high-resolution mass spectrometry, we analyzed VLCDCA 28:4 in the plasma...

Full description

Bibliographic Details
Main Authors: Paul L. Wood, Michelle M. Donohue, John E. Cebak, Taylor G. Beckmann, Márcia Cristina Fernandes Messias, Laura Credidio, Cláudio Saddy Rodrigues Coy, Patrícia de Oliveira Carvalho, Sara Crotti, Sara D’Aronco, Emanuele D.L. Urso, Marco Agostini
Format: Article
Language:English
Published: MDPI AG 2018-12-01
Series:Metabolites
Subjects:
colorectal cancer
inflammation
very-long-chain dicarboxylic acid 28:4
familial adenomatous polyposis
high-resolution mass spectrometry
cancer biomarker
Online Access:https://www.mdpi.com/2218-1989/8/4/91

Internet

https://www.mdpi.com/2218-1989/8/4/91

Similar Items